OutSee raised £1.8M seed funding to expand its Nomaly AI platform for predictive genomics drug target identification.
OutSee is a genomics-led discovery company that utilizes a predictive AI engine named Nomaly to analyze genomes and predict diseases and phenotypes ab initio, uncovering the underlying biological mechanisms that drive diseases
OutSee is a genomics-led discovery company that utilizes a predictive AI engine named Nomaly to analyze genomes and predict diseases and phenotypes ab initio, uncovering the underlying biological mechanisms that drive diseases.